Chemist for You Wegovy listings: what they tell you and what they don't

The myth: any regulated chemist selling Wegovy is essentially the same

When people search for Chemist for You Wegovy, the assumption is often that comparing pharmacies is like comparing supermarkets: same product, different shelf price, pick the cheapest. That's understandable, but it misses something significant.

Wegovy is a Prescription-Only Medicine. The clinical process wrapped around it (how thoroughly your history is reviewed, whether a real prescriber reads your answers or a system auto-flags them, what happens if you have a question at 7pm on a Saturday) varies enormously between providers. The pen that arrives is identical; the service behind it is not.

A GPhC-registered pharmacy can legally dispense Wegovy. That's the floor, not the ceiling. What actually protects you is the depth of the clinical review. For a medicine that affects how your gut and brain communicate, and that carries a detailed safety profile covered in full on our Wegovy page, that review matters more than the price difference between providers.

The NHS patient information on semaglutide sets out the conditions and medicines that affect suitability. A good prescriber will cross-reference all of them before approving treatment.

What Wegovy actually does, and why the 15% trial figure has conditions attached

Semaglutide works by mimicking GLP-1, a gut hormone that signals fullness to the brain and slows the rate at which your stomach empties, and you can read more about the underlying biology on our semaglutide chemistry page. The result, for most people, is a meaningful reduction in appetite and, over months, in body weight.

The STEP 1 trial, published in the New England Journal of Medicine, recorded an average weight reduction of around 15% over 68 weeks at the 2.4 mg maintenance dose. That figure comes from a trial conducted alongside structured lifestyle support, it isn't a standalone pill result. The participants who did best combined the medicine with a reduced-calorie diet and increased physical activity.

The MHRA also approved a 7.2 mg dose in early 2026, with trials reporting around 20.7% average weight loss at that level. Whether that higher dose is appropriate for any individual is a clinical question, not a marketing one. You can read a fuller breakdown of the evidence on our semaglutide treatment page.

Worth knowing: oral semaglutide tablets (Wegovy tablets) received MHRA approval in June 2026 as the first oral GLP-1 medicine licensed in the UK for weight management, giving people who prefer to avoid injections a clinical alternative. Ask about this at consultation if it's relevant to you.

How to evaluate any chemist offering Wegovy, including what to ask

Before placing an order with any online pharmacy for a prescription weight-loss medicine, three checks are worth five minutes of your time.

First, verify the pharmacy on the GPhC register. The General Pharmaceutical Council's register is publicly searchable. If a pharmacy doesn't appear there, stop. Second, check whether a real, named prescriber reviews your consultation, not an algorithm, not an automated eligibility checker. Third, look at what happens after your order arrives. A medicine that causes nausea in the early weeks, or raises questions about your other medications, needs a clinical team you can actually reach. Our contact and aftercare page explains how that works at nume.

The MHRA has been clear in its public guidance that large quantities of fake weight-loss pens have been seized from illegal sellers, with some containing insulin rather than semaglutide. Sellers offering prescription medicines without a clinical assessment are a firm red flag, report them via the Yellow Card scheme.

If you want to understand the cost picture before starting, our Wegovy cost page covers what private treatment typically involves and what a single transparent price should include.

Who Wegovy is licensed for, and the questions a prescriber will ask

Under its UK licence, Wegovy is indicated for adults with a BMI of 30 or above, or 27 to 29.9 with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance.

That's the starting point, not the end of the conversation. A prescriber will also consider your current medicines, any history of pancreatitis or thyroid conditions, whether you're pregnant or breastfeeding, and how your kidneys and liver are functioning. The is Wegovy for me page walks through these eligibility questions in plain terms.

NICE recommends semaglutide (TA875) only within specialist weight management services and for a maximum of two years, the NHS route has specific criteria and often long waiting lists. Private treatment through a regulated pharmacy is the practical alternative for people who don't meet the current NHS thresholds or can't wait, and our Daily Chemist Wegovy page explains how our service compares for those weighing up their options. You can explore the full picture of weight-loss treatment options to see how Wegovy sits alongside other approaches.

One practical note: if you order before 12pm on a weekday and your consultation is approved the same day, dispatch goes out that afternoon, useful context if you're planning around a week's commitments. That's the kind of detail that separates a genuine clinical service from a dispatch warehouse.

Our clinical team, led by our clinical director, reviews every consultation personally before any treatment is approved or sent.